Vaxart seeks stockholder approval for reverse split
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vaxart Inc (VXRT)
Vaxart Inc stock price live, this page displays NASDAQ VXRT stock exchange data. View the VXRT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vaxart Inc real time stock price chart below.
What Is the Vaxart Inc Stock Price Today?
The Vaxart Inc stock price today is 0.4196.
What Is the Stock Symbol for Vaxart Inc?
The stock ticker symbol for Vaxart Inc is VXRT.
Is VXRT the Same as $VXRT?
$VXRT is a common way to refer to the Vaxart Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Vaxart Inc Trade On?
Vaxart Inc is listed and trades on the NASDAQ stock exchange.
Is Vaxart Inc a Good Stock to Buy?
Determining whether Vaxart Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Vaxart Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VXRT quote. (ISIN: US92243A2006)
What Is the Vaxart Inc Stock Price Today?
The Vaxart Inc stock price today is 0.4196.
What Is the Stock Symbol for Vaxart Inc?
The stock ticker symbol for Vaxart Inc is VXRT.
Is VXRT the Same as $VXRT?
$VXRT is a common way to refer to the Vaxart Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Vaxart Inc Trade On?
Vaxart Inc is listed and trades on the NASDAQ stock exchange.
Is Vaxart Inc a Good Stock to Buy?
Determining whether Vaxart Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Vaxart Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VXRT quote. (ISIN: US92243A2006)
0.4196
+0.0126(+3.10%)
Closed·
Pre Market
0.4100-0.0096(-2.29%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3900
0.4249
52 wk Range
0.2850
1.0700
VXRT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected tomorrow
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.39000.4249
52 wk Range
0.28501.0700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VXRT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
6.0000
Upside
+1,329.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Vaxart resumes BARDA-funded trial activities
- Investing.com
- Vaxart seeks stockholder approval for reverse split
- Investing.com
Vaxart Inc Company Profile
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company’s product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.
Vaxart Inc Earnings Call Summary for Q4/2024
- Q4 2024 EPS missed at -$0.33 vs -$0.10 forecast; revenue beat at $28.7M vs $20.77M expected
- Revenue up 303% YoY; cash runway extended to Q4 2025 despite EPS miss
- Norovirus vaccine Phase 1 data expected mid-2025; Phase 2/3 studies planned
- Stock resilient post-earnings; up 2.11% in aftermarket despite 2.79% regular session drop
- BARDA stop work order impacts COVID-19 program; company exploring partnerships and non-dilutive funding
Last Updated: 03/20/2025, 05:17 PM
Read Full TranscriptCompare VXRT to Peers and Sector
Metrics to compare | VXRT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVXRTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −0.6x | −0.5x | |
PEG Ratio | −0.03 | −0.01 | 0.00 | |
Price / Book | 1.6x | 2.0x | 2.6x | |
Price / LTM Sales | 3.3x | 12.7x | 2.9x | |
Upside (Analyst Target) | - | 351.1% | 53.4% | |
Fair Value Upside | Unlock | 15.0% | 10.2% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.0000
(+1,329.93% Upside)
Earnings
Latest Release
Mar 20, 2025
EPS / Forecast
-0.33 / -0.10
Revenue / Forecast
28.70M / 20.77M
People Also Watch
FAQ
What Is the Vaxart (VXRT) Stock Price Today?
The Vaxart stock price today is 0.42
What Stock Exchange Does Vaxart Trade On?
Vaxart is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Vaxart?
The stock symbol for Vaxart is "VXRT."
What Is the Vaxart Market Cap?
As of today, Vaxart market cap is 95.65M.
What Is Vaxart's Earnings Per Share (TTM)?
The Vaxart EPS (TTM) is -0.33.
When Is the Next Vaxart Earnings Date?
Vaxart will release its next earnings report on May 13, 2025.
From a Technical Analysis Perspective, Is VXRT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.